| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.120 | 40.878 | 8.125 | 2.434 | 1.391 | - | - | - | - | - |
| Total Income - EUR | 9.411 | 43.589 | 11.760 | 3.517 | 1.391 | - | - | - | - | - |
| Total Expenses - EUR | 24.897 | 36.776 | 17.130 | 9.789 | 4.094 | - | - | - | - | - |
| Gross Profit/Loss - EUR | -15.487 | 6.814 | -5.370 | -6.272 | -2.703 | - | - | - | - | - |
| Net Profit/Loss - EUR | -15.640 | 6.405 | -6.046 | -6.376 | -2.726 | - | - | - | - | - |
| Employees | 2 | 2 | 1 | 1 | 0 | - | - | - | - | - |
Check the financial reports for the company - Diosan Bioprod Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 29.557 | 27.947 | 22.703 | 17.185 | 11.008 | - | - | - | - | - |
| Current Assets | 6.142 | 13.002 | 3.024 | 2.496 | 4.831 | - | - | - | - | - |
| Inventories | 2.633 | 4.174 | 1.387 | 0 | 0 | - | - | - | - | - |
| Receivables | 3.297 | 7.600 | 1.250 | 2.496 | 3.178 | - | - | - | - | - |
| Cash | 212 | 1.228 | 387 | 0 | 1.653 | - | - | - | - | - |
| Shareholders Funds | -18.125 | -14.540 | -20.341 | -26.343 | -28.559 | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | - | - | - | - | - |
| Debts | 49.803 | 51.510 | 46.068 | 46.024 | 44.399 | - | - | - | - | - |
| Income in Advance | 4.020 | 3.979 | 0 | 0 | 0 | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1032 - 1032" | |||||||||
| CAEN Financial Year |
1032
|
|||||||||
Comments - Diosan Bioprod Srl